Published in Ambul Pediatr on March 13, 2006
Antipsychotic treatment among youth in foster care. Pediatrics (2011) 1.33
The relationship between mental health diagnosis and treatment with second-generation antipsychotics over time: a national study of U.S. Medicaid-enrolled children. Health Serv Res (2012) 1.26
First do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents. J Can Acad Child Adolesc Psychiatry (2010) 1.25
Relationship between body mass index and medical care expenditures for North Carolina adolescents enrolled in Medicaid in 2004. Prev Chronic Dis (2007) 1.03
The dopamine dilemma: using stimulants and antipsychotics concurrently. Psychiatry (Edgmont) (2010) 0.95
Adolescent experience of psychotropic treatment. Transcult Psychiatry (2009) 0.89
The effects of prior authorization policies on medicaid-enrolled children's use of antipsychotic medications: evidence from two mid-Atlantic states. J Child Adolesc Psychopharmacol (2014) 0.87
A Qualitative Study of Antipsychotic Medication Experiences of Youth. J Can Acad Child Adolesc Psychiatry (2015) 0.86
Clinical characteristics of children receiving antipsychotic medication. J Child Adolesc Psychopharmacol (2011) 0.86
Prescribing trends of antipsychotics in youth receiving income assistance: results from a retrospective population database study. BMC Psychiatry (2013) 0.85
Increasing use of atypical antipsychotics and anticonvulsants during pregnancy. Pharmacoepidemiol Drug Saf (2012) 0.84
Suicidal behavior differs among early and late adolescents treated with antidepressant agents. Pediatrics (2011) 0.84
Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents. Ther Adv Psychopharmacol (2013) 0.84
Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs. Front Psychiatry (2012) 0.83
System struggles and substitutes: A qualitative study of general practitioner and psychiatrist experiences of prescribing antipsychotics to children and adolescents. Clin Child Psychol Psychiatry (2015) 0.83
National trends in off-label use of atypical antipsychotics in children and adolescents in the United States. Medicine (Baltimore) (2016) 0.82
Antipsychotic prescribing in youths: a French community-based study from 2006 to 2013. Eur Child Adolesc Psychiatry (2015) 0.81
Medication adherence for children and adolescents with first-episode psychosis following hospitalization. Eur Child Adolesc Psychiatry (2009) 0.80
Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients. Neuropsychiatr Dis Treat (2010) 0.80
Multiple psychiatric diagnoses common in privately insured children on atypical antipsychotics. Clin Pediatr (Phila) (2010) 0.79
Treatment patterns, resource use, and economic outcomes associated with atypical antipsychotic prescriptions in children and adolescents with attention-deficit hyperactivity disorder in quebec. Can J Psychiatry (2014) 0.79
Behavior analysis in the era of medicalization: the state of the science and recommendations for practitioners. Behav Anal Pract (2009) 0.78
Evaluation of monitoring for metabolic effects in children treated with second generation antipsychotics in a pediatric clinic. J Pediatr Pharmacol Ther (2013) 0.77
The voices go, but the song remains the same: how can we rescue cognition in early-onset schizophrenia? J Am Acad Child Adolesc Psychiatry (2012) 0.77
The effects of industry sponsorship on comparator selection in trial registrations for neuropsychiatric conditions in children. PLoS One (2013) 0.77
Long-Term Aripiprazole in Youth With Developmental Disabilities Including Autism. J Ment Health Res Intellect Disabil (2011) 0.76
Patterns of psychotropic medication prescriptions by psychiatrists for private clinic outpatients in kerman province, iran. Sultan Qaboos Univ Med J (2014) 0.76
Commentary on: "Review of the Pharmacotherapy of Irritability of Autism": A Skeptic's View on Second Generation Antipsychotics in Autism. J Can Acad Child Adolesc Psychiatry (2012) 0.75
Patterns of Antipsychotic Prescribing by Physicians to Young Children. Psychiatr Serv (2016) 0.75
Analysis of pediatric clinical drug trials for neuropsychiatric conditions. Pediatrics (2013) 0.75
The interdependence of behavioral and somatic health: implications for conceptualizing health and measuring treatment outcomes. Int J Integr Care (2007) 0.75
759C/T Variants of the Serotonin (5-HT2C) Receptor Gene and Weight Gain in Children and Adolescents in Long-Term Risperidone Treatment. Clin Pharmacol Biopharm (2013) 0.75
Evidence review and clinical guidance for the use of ziprasidone in Canada. Ann Gen Psychiatry (2013) 0.75
Incidence of adverse events in antipsychotic-naïve children and adolescents treated with antipsychotic drugs: a French multicentre naturalistic study protocol (ETAPE). BMJ Open (2016) 0.75
Azithromycin and the risk of cardiovascular death. N Engl J Med (2012) 8.18
Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med (2006) 6.83
Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet (2007) 5.50
Potential for conflict of interest in the evaluation of suspected adverse drug reactions: use of cerivastatin and risk of rhabdomyolysis. JAMA (2004) 4.71
Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med (2005) 4.04
ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med (2011) 3.12
Immortal time bias in critical care research: application of time-varying Cox regression for observational cohort studies. Crit Care Med (2009) 2.96
New users of antipsychotic medications among children enrolled in TennCare. Arch Pediatr Adolesc Med (2004) 2.80
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults. JAMA (2011) 2.77
Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol (2007) 2.62
Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis (2007) 2.60
Diagnosing delirium in critically ill children: Validity and reliability of the Pediatric Confusion Assessment Method for the Intensive Care Unit. Crit Care Med (2011) 2.59
COX-2 selective non-steroidal anti-inflammatory drugs and risk of serious coronary heart disease. Lancet (2002) 2.49
Increased risk of adrenal insufficiency following etomidate exposure in critically injured patients. Arch Surg (2008) 2.38
Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma (2007) 2.08
A computer case definition for sudden cardiac death. Pharmacoepidemiol Drug Saf (2010) 1.97
Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry (2013) 1.95
Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes (2009) 1.90
The aprotinin story--is BART the final chapter? N Engl J Med (2008) 1.84
Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis (2004) 1.84
Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Gastroenterology (2007) 1.80
Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Obstet Gynecol (2002) 1.70
The Preschool Confusion Assessment Method for the ICU: Valid and Reliable Delirium Monitoring for Critically Ill Infants and Children. Crit Care Med (2016) 1.69
Improving medication use in newly admitted home healthcare patients: a randomized controlled trial. J Am Geriatr Soc (2002) 1.69
Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Am J Med (2005) 1.68
Influenza H7N9 and H9N2 viruses: coexistence in poultry linked to human H7N9 infection and genome characteristics. J Virol (2014) 1.67
Use of disease risk scores in pharmacoepidemiologic studies. Stat Methods Med Res (2008) 1.65
Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis. Med Care (2007) 1.62
Medical care utilization and mortality in sickle cell disease: a population-based study. Am J Hematol (2005) 1.61
Resident work hour limits and patient safety. Ann Surg (2005) 1.58
Health care access of Hispanic young adults in the United States. J Adolesc Health (2006) 1.55
The rising prevalence of gastroschisis and omphalocele in Tennessee. J Pediatr Surg (2007) 1.52
Adjustment for multiple cardiovascular risk factors using a summary risk score. Epidemiology (2008) 1.52
Relationship between domestic and wild birds in live poultry market and a novel human H7N9 virus in China. J Infect Dis (2013) 1.50
Trends in healthcare usage attributable to diarrhea, 1995-2004. J Pediatr (2008) 1.46
Pursuing professional accountability: an evidence-based approach to addressing residents with behavioral problems. Arch Surg (2012) 1.43
A plan for identification, treatment, and remediation of disruptive behaviors in physicians. Front Health Serv Manage (2009) 1.42
Postmarketing surveillance for drug safety: surely we can do better. Clin Pharmacol Ther (2004) 1.41
Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol. Am J Respir Crit Care Med (2002) 1.40
An analysis of risk factors for patient complaints about ambulatory anesthesiology care. Anesth Analg (2013) 1.40
Cardiovascular toxicity of valdecoxib. N Engl J Med (2004) 1.39
Utility of daily supervised hyperventilation during long-term video-EEG monitoring. J Clin Neurophysiol (2009) 1.39
Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J Perinatol (2004) 1.39
Performance of disease risk scores, propensity scores, and traditional multivariable outcome regression in the presence of multiple confounders. Am J Epidemiol (2011) 1.37
Outpatient adherence to beta-blocker therapy after acute myocardial infarction. J Am Coll Cardiol (2002) 1.31
Black race, sex, and extrapulmonary tuberculosis risk: an observational study. BMC Infect Dis (2010) 1.29
National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology (2005) 1.29
Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med (2002) 1.21
Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge. J Am Coll Cardiol (2004) 1.19
Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine. Pediatr Infect Dis J (2004) 1.19
Implementation of a real-time compliance dashboard to help reduce SICU ventilator-associated pneumonia with the ventilator bundle. Arch Surg (2009) 1.19
A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? (United States). Cancer Causes Control (2004) 1.17
Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen. J Biol Chem (2010) 1.16
An automated database case definition for serious bleeding related to oral anticoagulant use. Pharmacoepidemiol Drug Saf (2011) 1.14
Improved compliance with quality measures at hospital discharge with a computerized physician order entry system. Am Heart J (2006) 1.12
Expression and regulation of a novel identified TNFAIP8 family is associated with diabetic nephropathy. Biochim Biophys Acta (2010) 1.12
Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality? Arch Surg (2007) 1.12
Initiation of rheumatoid arthritis treatments and the risk of serious infections. Rheumatology (Oxford) (2009) 1.10
Comparative effectiveness of antibiotic treatment strategies for pediatric skin and soft-tissue infections. Pediatrics (2011) 1.08
Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke. Stroke (2008) 1.04
Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action. Neurosci Lett (2005) 1.04
Effect of regulatory warnings on antidepressant prescribing for children and adolescents. Arch Pediatr Adolesc Med (2007) 1.04
Identification of the N-terminal peptide binding site of glucose-regulated protein 94. J Biol Chem (2004) 1.04
Prescriptions for chronic high-dose cyclooxygenase-2 inhibitors are often inappropriate and potentially dangerous. J Gen Intern Med (2005) 1.04
Risk factors for pressure ulcers in acute care hospitals. Wound Repair Regen (2008) 1.02
The ethics of placebo in studies with fracture end points in osteoporosis. N Engl J Med (2010) 1.01
Prescriptions for contraindicated category X drugs in pregnancy among women enrolled in TennCare. Paediatr Perinat Epidemiol (2004) 0.99
Identifying suicidal behavior among adolescents using administrative claims data. Pharmacoepidemiol Drug Saf (2013) 0.98
Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations. Paediatr Perinat Epidemiol (2009) 0.98
Work hours restrictions as an ethical dilemma for residents: a descriptive survey of violation types and frequency. Curr Surg (2006) 0.97
Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study. Paediatr Perinat Epidemiol (2012) 0.96
Epidemiology of the avian influenza A (H7N9) outbreak in Zhejiang Province, China. BMC Infect Dis (2014) 0.96
Reducing blood culture contamination in the emergency department: an interrupted time series quality improvement study. Acad Emerg Med (2013) 0.96
Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease. Pharmacoepidemiol Drug Saf (2009) 0.95
Delirium: an emerging frontier in the management of critically ill children. Crit Care Clin (2009) 0.95
Positive predictive value of computerized records for major congenital malformations. Pharmacoepidemiol Drug Saf (2008) 0.94
Inhibition of angiotensin II signaling and recurrence of atrial fibrillation in AFFIRM. Heart Rhythm (2004) 0.93
Family reports of care denials for children enrolled in TennCare. Pediatrics (2004) 0.93
Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs. Arthritis Rheum (2002) 0.92